Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 6, 2020
Anti-cytokines as a Strategy in Alpha-1 Antitrypsin DeficiencyOisín F McElvaney, Mark P Murphy, Emer P Reeves, et al.Expert Review of Respiratory Medicine|March 10, 2023
Alpha-1 antitrypsin deficiency: current therapy and emerging targetsOisín F McElvaney, Daniel D Fraughen, Oliver J McElvaney, et al.Anesthesiology|March 15, 2021
α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?Grace Hogan, Pierce Geoghegan, Tomás P Carroll, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individualsKillian Hurley, Noreen Lacey, Ciara A O'Dwyer, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 8, 2020
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19Oliver J McElvaney, Eoin O'Connor, Natalie L McEvoy, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 11, 2022
Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.Thorax|May 19, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosisMichelle Casey, Claudie Gabillard-Lefort, Oisín F McElvaney, et al.Ebiomedicine|October 11, 2020
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19Oliver J McElvaney, Brian D Hobbs, Dandi Qiao, et al.The European Respiratory Journal|February 16, 2020
α1 Antitrypsin therapy modulates the neutrophil membrane proteome and secretomeMark P Murphy, Thomas McEnery, Karen McQuillan, et al.BMC Research Notes|January 10, 2021
Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patientsJennifer Clarke, Pierce Geoghegan, Natalie McEvoy, et al.Pageof 2